• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

制备山奈酚磷脂复合物以提高其溶解度和抗高尿酸血症活性。

Preparation of an isorhamnetin phospholipid complex for improving solubility and anti-hyperuricemia activity.

机构信息

School of Traditional Chinese Material Medica, Shenyang Pharmaceutical University, Shenyang, China.

Faculty of Functional Food and Wine, Shenyang Pharmaceutical University, Shenyang, China.

出版信息

Pharm Dev Technol. 2022 Sep;27(7):842-852. doi: 10.1080/10837450.2022.2123510. Epub 2022 Sep 16.

DOI:10.1080/10837450.2022.2123510
PMID:36083162
Abstract

To improve the solubility and anti-hyperuricemia activity of the insoluble natural flavonoid isorhamnetin (ISO), an isorhamnetin phospholipid complex (ISO-PC) was prepared. ISO-PC was prepared through solvent evaporation and its prescription process was optimized. The formation of ISO-PC was verified via multiple characterization methods. Parameters such as drug loading, solubility, octanol-water partition coefficient, stability, and anti-hyperuricemia activity of ISO-PC were investigated. The complexation efficiency of ISO-PC was 95.1% ± 0.56%. The characterization results confirmed that ISO-PC was bound by intermolecular interactions between ISO and phospholipids. Compared with ISO, the solubility of ISO-PC in water and 1-octanol increased by 122 and 16.5 times, respectively. In addition, the octanol-water partition coefficient decreased to 1.08. Pharmacodynamic studies have reported that ISO-PC has a more significant effect on reducing serum uric acid levels and renal protection. In conclusion, the findings of this study suggested that ISO-PC could be used as a promising formulation to improve the solubility and the anti-hyperuricemia activity of ISO.

摘要

为提高不溶性天然类黄酮山柰素(ISO)的溶解度和抗高尿酸血症活性,制备了山柰素磷脂复合物(ISO-PC)。通过溶剂蒸发法制备 ISO-PC,并对其处方工艺进行优化。采用多种表征方法验证了 ISO-PC 的形成。考察了 ISO-PC 的载药量、溶解度、油水分配系数、稳定性和抗高尿酸血症活性等参数。ISO-PC 的包合效率为 95.1%±0.56%。表征结果证实 ISO-PC 是通过 ISO 和磷脂分子间的相互作用结合而成。与 ISO 相比,ISO-PC 在水中和 1-辛醇中的溶解度分别提高了 122 倍和 16.5 倍。此外,油水分配系数降低至 1.08。药效学研究报道,ISO-PC 对降低血尿酸水平和肾脏保护作用更显著。综上所述,本研究结果表明,ISO-PC 可作为提高 ISO 溶解度和抗高尿酸血症活性的一种有前途的制剂。

相似文献

1
Preparation of an isorhamnetin phospholipid complex for improving solubility and anti-hyperuricemia activity.制备山奈酚磷脂复合物以提高其溶解度和抗高尿酸血症活性。
Pharm Dev Technol. 2022 Sep;27(7):842-852. doi: 10.1080/10837450.2022.2123510. Epub 2022 Sep 16.
2
A phospholipid complex to improve the oral bioavailability of flavonoids.一种用于提高类黄酮口服生物利用度的磷脂复合物。
Drug Dev Ind Pharm. 2015;41(10):1693-703. doi: 10.3109/03639045.2014.991402. Epub 2014 Dec 11.
3
Preparation of ursolic acid-phospholipid complex by solvent-assisted grinding method to improve dissolution and oral bioavailability.溶剂辅助研磨法制备熊果酸-磷脂复合物以提高其溶解性能和口服生物利用度。
Pharm Dev Technol. 2020 Jan;25(1):68-75. doi: 10.1080/10837450.2019.1671864. Epub 2019 Oct 1.
4
[Preparation, formation mechanism and preliminary evaluation of oral absorption of a Bicyclol-phospholipid complex].双环醇磷脂复合物的制备、形成机制及口服吸收初步评价
Yao Xue Xue Bao. 2014 Nov;49(11):1600-6.
5
Improved oral bioavailability and therapeutic efficacy of erlotinib through molecular complexation with phospholipid.通过与磷脂的分子复合提高厄洛替尼的口服生物利用度和治疗效果。
Int J Pharm. 2017 Dec 20;534(1-2):1-13. doi: 10.1016/j.ijpharm.2017.09.071. Epub 2017 Sep 29.
6
Development of quercetin-phospholipid complex to improve the bioavailability and protection effects against carbon tetrachloride-induced hepatotoxicity in SD rats.槲皮素-磷脂复合物的研制,以提高其在SD大鼠体内的生物利用度及对四氯化碳诱导的肝毒性的保护作用。
Fitoterapia. 2016 Sep;113:102-9. doi: 10.1016/j.fitote.2016.07.008. Epub 2016 Jul 16.
7
Novel rifampicin-phospholipid complex for tubercular therapy: synthesis, physicochemical characterization and in-vivo evaluation.新型利福平-磷脂复合物用于结核病治疗:合成、理化性质表征及体内评价。
Int J Pharm. 2014 Jan 2;460(1-2):220-7. doi: 10.1016/j.ijpharm.2013.10.043. Epub 2013 Nov 1.
8
Phytophospholipid Complex of Caffeic Acid: Development, In vitro Characterization, and In Vivo Investigation of Antihyperlipidemic and Hepatoprotective Action in Rats.咖啡酸植物磷酯复合物:制剂开发、体外特性鉴定及在大鼠体内抗高血脂和保肝作用的研究。
AAPS PharmSciTech. 2021 Jan 6;22(1):28. doi: 10.1208/s12249-020-01887-7.
9
Role of a novel pyridostigmine bromide-phospholipid nanocomplex in improving oral bioavailability.新型溴化吡斯的明-磷脂纳米复合物在提高口服生物利用度中的作用。
Arch Pharm Res. 2012 Mar;35(3):499-508. doi: 10.1007/s12272-012-0313-6. Epub 2012 Apr 5.
10
Preparation and evaluation of a self-nanoemulsifying drug delivery system loaded with Akebia saponin D-phospholipid complex.载有三叶木通皂苷 D-磷脂复合物的自微乳给药系统的制备与评价。
Int J Nanomedicine. 2016 Sep 26;11:4919-4929. doi: 10.2147/IJN.S108765. eCollection 2016.

引用本文的文献

1
Isorhamnetin: Reviewing Recent Developments in Anticancer Mechanisms and Nanoformulation-Driven Delivery.异鼠李素:抗癌机制及纳米制剂驱动递送的最新进展综述
Int J Mol Sci. 2025 Jul 30;26(15):7381. doi: 10.3390/ijms26157381.
2
Decoding PANoptosis in Gout: Signature Gene Identification and Immune Infiltration Profiling.痛风中全程序性坏死的解码:特征基因鉴定与免疫浸润分析
Int J Rheum Dis. 2025 Jul;28(7):e70344. doi: 10.1111/1756-185X.70344.
3
Modification of biopharmaceutical parameters of flavonoids: a review.黄酮类化合物生物制药参数的修饰:综述
Front Chem. 2025 Apr 29;13:1602967. doi: 10.3389/fchem.2025.1602967. eCollection 2025.
4
Ultrasound-assisted preparation of wax-based composite gelator: Structural characterisation, in vitro antioxidant activity and application in oleogels.超声辅助制备蜡基复合凝胶剂:结构表征、体外抗氧化活性及在油凝胶中的应用
Ultrason Sonochem. 2025 Mar;114:107253. doi: 10.1016/j.ultsonch.2025.107253. Epub 2025 Feb 9.
5
Modulation of redox-sensitive transcription factors with polyphenols as pathogenetically grounded approach in therapy of systemic inflammatory response.以多酚调节氧化还原敏感转录因子作为全身炎症反应治疗中基于发病机制的方法。
Heliyon. 2023 Apr 16;9(5):e15551. doi: 10.1016/j.heliyon.2023.e15551. eCollection 2023 May.